ClariMed Inc. Expands European Presence with New Office in Leeds, UK
CHADDS FORD, Pa., Aug. 28, 2024 /PRNewswire/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory...
Pharmaceutical
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO,...
EydisBio Awarded $2.6 Million Grant to Advance TAK1 Inhibitor Program for Systemic Sclerosis
DURHAM, N.C., Aug. 28, 2024 /PRNewswire/ -- EydisBio, an early-stage pharmaceutical company leveraging a novel approach to treating various autoimmune...
FlackTek™ Technology Reduces Cannabinoid Degradation During Solvent Removal
LANDRUM, S.C., Aug. 28, 2024 /PRNewswire/ -- A pivotal study, "Approaches to Mitigate Cannabinoid Degradation During Solvent Removal," showcases how...
Formedics Acquires AMC Media Group Amplifying Its Content and Peer-to-Peer HCP Community
Formedics—home to flagships Physician's Weekly, Figure 1, and OncWeekly—grows reach by more than 60% to 1.5 million opted-in physicians, nurse...
Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer
TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
BOULDER, CO / ACCESSWIRE / August 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company...
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million
SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees...
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the...
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage...
Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program
Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF), a clinical-stage biotechnology company...
Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial
Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. -...
Glytec Expands Global Collaboration with Roche to Revolutionize Hospital Diabetes Management
BOSTON, Aug. 27, 2024 /PRNewswire/ -- Glytec, a trailblazer in diabetes and insulin management software, announced today the expansion of...
MasterControl Kicks Off Generative AI-Powered Document Translator Beta Program
AI-powered Document Translator empowers users to streamline their processes to translate and globally distribute critical documents necessary for training and...
Bluesight Appoints Mark Peters as Chief Financial Officer
New financial leader joins leadership team to support continued growth ALEXANDRIA, Va., Aug. 27, 2024 /PRNewswire/ -- Bluesight, the leading...
Aquila Solutions to Feature at RAPS Convergence 2024
WARNER ROBINS, Ga., Aug. 27, 2024 /PRNewswire/ -- Aquila Solutions, a prominent provider of regulatory solutions for small to medium-sized pharmaceutical...
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study
BRENTWOOD, Tenn., Aug. 27, 2024 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced the results of a Cardiovascular Health Outcomes Analysis...
Hexaware and Blumetra Partner to Enhance Data Management
Delivering MDM SaaS Solutions for the Life Sciences Industry ISELIN, N.J., Aug. 27, 2024 /PRNewswire/ -- Hexaware Technologies, a provider of...